Globus Medical Inc has a consensus price target of $64.26, established from looking at the 63 latest analyst ratings. The last 3 analyst ratings were released from BTIG, Stifel, and Truist Securities on March 18, 2024, February 21, 2024, and February 21, 2024. With an average price target of $61.33 between BTIG, Stifel, and Truist Securities, there's an implied 14.34% upside for Globus Medical Inc from these 3 analyst ratings.
1calculated from analyst ratings published within the last 3 years
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|
03/18/2024 | GMED | Buy Now | Globus Medical | $53.64 | 11.86% | BTIG | Ryan Zimmerman | → $60 | Upgrade | Neutral → Buy | Get Alert |
02/21/2024 | GMED | Buy Now | Globus Medical | $53.64 | 19.31% | Stifel | Mathew Blackman | $61 → $64 | Maintains | Buy | Get Alert |
02/21/2024 | GMED | Buy Now | Globus Medical | $53.64 | 11.86% | Truist Securities | Richard Newitter | $58 → $60 | Maintains | Hold | Get Alert |
01/11/2024 | GMED | Buy Now | Globus Medical | $53.64 | 30.5% | RBC Capital | Shagun Singh | → $70 | Reiterates | Outperform → Outperform | Get Alert |
12/22/2023 | GMED | Buy Now | Globus Medical | $53.64 | 8.13% | Truist Securities | Richard Newitter | $53 → $58 | Maintains | Hold | Get Alert |
12/20/2023 | GMED | Buy Now | Globus Medical | $53.64 | 32.36% | Canaccord Genuity | Kyle Rose | $67 → $71 | Maintains | Buy | Get Alert |
11/14/2023 | GMED | Buy Now | Globus Medical | $53.64 | -1.19% | Morgan Stanley | Drew Ranieri | $60 → $53 | Maintains | Equal-Weight | Get Alert |
11/08/2023 | GMED | Buy Now | Globus Medical | $53.64 | -1.19% | Truist Securities | Richard Newitter | $58 → $53 | Maintains | Hold | Get Alert |
10/20/2023 | GMED | Buy Now | Globus Medical | $53.64 | 39.82% | Roth MKM | Jason Wittes | → $75 | Initiates | → Buy | Get Alert |
10/12/2023 | GMED | Buy Now | Globus Medical | $53.64 | 60.33% | Barclays | Matt Miksic | $77 → $86 | Maintains | Overweight | Get Alert |
09/19/2023 | GMED | Buy Now | Globus Medical | $53.64 | 13.72% | Stifel | Mathew Blackman | → $61 | Upgrade | Hold → Buy | Get Alert |
09/15/2023 | GMED | Buy Now | Globus Medical | $53.64 | 8.13% | Wells Fargo | Vik Chopra | $63 → $58 | Maintains | Equal-Weight | Get Alert |
09/05/2023 | GMED | Buy Now | Globus Medical | $53.64 | 21.18% | Truist Securities | Richard Newitter | → $65 | Reiterates | Hold → Hold | Get Alert |
08/07/2023 | GMED | Buy Now | Globus Medical | $53.64 | 21.18% | Truist Securities | Richard Newitter | $68 → $65 | Maintains | Hold | Get Alert |
08/07/2023 | GMED | Buy Now | Globus Medical | $53.64 | 43.55% | Barclays | Matt Miksic | $75 → $77 | Maintains | Overweight | Get Alert |
08/04/2023 | GMED | Buy Now | Globus Medical | $53.64 | 17.45% | Wells Fargo | Vik Chopra | $61 → $63 | Maintains | Equal-Weight | Get Alert |
07/19/2023 | GMED | Buy Now | Globus Medical | $53.64 | 26.77% | Truist Securities | Richard Newitter | $64 → $68 | Maintains | Hold | Get Alert |
05/31/2023 | GMED | Buy Now | Globus Medical | $53.64 | 11.86% | Morgan Stanley | Drew Ranieri | $64 → $60 | Maintains | Equal-Weight | Get Alert |
05/24/2023 | GMED | Buy Now | Globus Medical | $53.64 | — | JMP Securities | David Turkaly | — | Reiterates | → Market Perform | Get Alert |
The latest price target for Globus Medical (NYSE: GMED) was reported by BTIG on March 18, 2024. The analyst firm set a price target for $60.00 expecting GMED to rise to within 12 months (a possible 11.86% upside). 21 analyst firms have reported ratings in the last year.
The latest analyst rating for Globus Medical (NYSE: GMED) was provided by BTIG, and Globus Medical upgraded their buy rating.
The last upgrade for Globus Medical Inc happened on March 18, 2024 when BTIG raised their price target to $60. BTIG previously had a neutral for Globus Medical Inc.
The last downgrade for Globus Medical Inc happened on February 13, 2023 when B of A Securities changed their price target from $83 to $63 for Globus Medical Inc.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Globus Medical, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Globus Medical was filed on March 18, 2024 so you should expect the next rating to be made available sometime around March 18, 2025.
While ratings are subjective and will change, the latest Globus Medical (GMED) rating was a upgraded with a price target of $0.00 to $60.00. The current price Globus Medical (GMED) is trading at is $53.64, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.